Huntsman Cancer Institute (HCI) is part of the University of Utah Health Care system, which ranked in the top 10 of all academic medical centers in the country in 2011—for the second year in a row. This ranking was given by the University HealthSystem Consortium's quality and accountability study.

2011 grants chartThis chart shows the total value of all cancer-focused grants and contracts held by our 159 Cancer Center members.

HCI has 159 distinguished faculty researchers, including 2007 Nobel Laureate Mario Capecchi, PhD. In 2011, HCI and its faculty researchers received $79.5 million in grant funding to support cancer research.

To date, three major building projects have been completed as part of HCI's "cancer campus."

After an expansion of the cancer hospital in 2011, HCI's clinical facilities now feature

  • 100 inpatient rooms
  • 55 chemotherapy infusion stations
  • More than 100 exam and procedure rooms

Additional patient care statistics in 2011:

  • 11,557 chemotherapy infusion visits
  • 22,738 radiation therapy treatments
  • 55,221 outpatient visits
  • 3,037 surgical cases

HCI moves science from the lab to the patient bedside with more than 200 clinical trials open at a given time.

HCI has the only Phase I (first-in-man) clinical research program between Denver and San Francisco.

In 2011, approximately 16% of HCI patients participated in a clinical trial, compared to a national average of less than 5%.

Each year, more than 1 million people access our award-winning website for cancer research and care information: www.huntsmancancer.org

HCI Financial Data*

2011 Revenue

2011 Expenditures

*Clinical revenues and expenses of HCI are not included in these amounts. Refer to the University of Utah Health Care annual report. Cancer-focused research revenues and expenses include only those Cancer Center members with research space at HCI.